Evidence map›Paper›PMID 42806691›Full record

ReviewImmunological reviews2026

Building an Interleukin-10-Producing Identity: How B Cells Acquire Interleukin-10 Competence and How Plasma Cell Differentiation Consolidates This Program.

Bui Thi Cuc, Yanli Tong, Zhiguo Wu, Daniel Alvarez-Simon, Simon Fillatreau

Abstract readReview
In one paragraph

Review in Immunological reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bui Thi CucINSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.
Yanli TongINSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.
Zhiguo WuINSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.
Daniel Alvarez-SimonINSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.
Simon FillatreauINSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-7730-9917

Funding

Agence Nationale de la RechercheAXA Research FundFondation pour la Recherche Médicale MND202310017967France Sclérose en Plaques
6 · The paper itself

Abstract

Interleukin (IL)-10-producing B cells represent an archetype for the regulatory functions of B cells. Here, we review the cell-surface receptors and transcriptional regulators that control IL-10 expression in B cells and enable their regulatory function in vivo. To integrate available data, we propose a three-layer competence-execution-stabilization (CES) framework for IL-10-mediated B cell regulation. We propose that B cell receptor signaling during B cell development and at homeostasis contributes to establishing high IL-10 competence in selected B cell subsets at steady state. Execution of IL-10 expression and regulatory function then requires the integration of canonical B cell activation pathways with environmental signals and involves transcriptional programs that are largely intertwined with those controlling plasma cell differentiation. Notably, chemically induced IL-10-producing B cells progressively differentiate into IL-10-producing plasma cells and acquire homogeneous and stable IL-10 expression. Together with LAG-3

Indexed as

B-LymphocytesB-Lymphocyte SubsetsInterleukin-10Plasma CellsAnimalsCell DifferentiationGene Expression RegulationHumansLymphocyte ActivationReceptors, Antigen, B-CellSignal TransductionInterleukin-10Receptors, Antigen, B-CellB cellsIL‐10plasma cellsregulatory B cellsregulatory plasma cells

Identifiers

PMID42806691
PMCPMC13620444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.